TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
FEMY

Femasys Inc

Healthcare · Medical Instruments & Supplies

2.40$ -5.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow FEMY
Line item 2019 2020 2021 2022 2023 2024 2025
-1,184.6% -475.3% -672.3% -889.7% -1,052.3% -1,193.5% -815.0%
117.8% 106.1% 81.7% 73.7% 84.7% 53.5% 35.1%
38.6% 30.7% 16.4% 18.6% 63.0% 27.3% 34.5%
27.1% 31.1% -52.9% 19.2% – – –
-116.3% 53.8% -62.1% -38.0% 113.9% -193.0% -89.7%
75.0% 3.1% 26.0% 33.8% 13.4% 46.8% 22.9%
1,325.8% 93.3% -26.0% -33.8% -13.4% -52.0% -27.5%
0.3% 14.8% – – – – –
-14.0% 76.4% -39.2% -43.8% 580.6% 0.0% 180.9%
-13.8% 84.0% 2,517.5% -56.5% 1,882.4% 124.5% 1,096.0%
127.4% -298.0% 1,819.2% -980.0% 816.6% -1,121.1% 253.5%
-1,259.6% -478.3% -698.3% -923.5% -1,065.7% -1,240.3% -837.9%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?